Supernus Pharmaceuticals | SUPN - Ebit

Stock Price
49.76
Daily Change
-0.63 -1.25%
Monthly
-0.60%
Yearly
54.44%
Q2 Forecast
48.70

Supernus Pharmaceuticals reported $13.82M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Abbott USD 1.85B 684M Mar/2026
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -35.79M 8.96M Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Cara Therapeutics USD -5.94M 3.55M Sep/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Eisai JPY 20.03B 6.36B Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Pacira USD 3.19M 9.96M Dec/2025
Perrigo USD 84.4M 9M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Xeris Pharmaceuticals USD 16.77M 8.88M Dec/2025